Pharmaceutical & Diagnostic Innovation

, Volume 3, Issue 11, pp 13–16 | Cite as

NO Time for Old Drugs

Novel Nitric Oxide Therapies from NicOx
Emerging Technology


Nitric Oxide Nitric Oxide Synthases Naproxen Allergic Rhinitis Rofecoxib 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327 (6122): 524–6PubMedCrossRefGoogle Scholar
  2. 2.
    Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333 (6174): 664–6PubMedCrossRefGoogle Scholar
  3. 3.
    European Biotechnology. NicOx. Change of price. Disappointing phase II data. New York: Lehman Brothers Global Equity Re-search, 2005Google Scholar
  4. 4.
    NicOx. NicOx announces results of a phase 2 trial for NCX 4016 in PAOD. Media release: 14 Nov 2005Google Scholar

Copyright information

© Adis Data Information BV 2005

Personalised recommendations